S
600529
vs
M
MDLN
S
600529
M
MDLN
Over the past 12 months, Shandong Pharmaceutical Glass Co Ltd has outperformed MDLN, delivering a return of -18% compared to the MDLN's 31% drop.
This Feature is Available on
Paid Plans
Paid Plans
This Feature is Available on Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
14-day money-back guarantee
Smart Verdict
AI-Powered
Not Sure Which Stock Wins?
Let AI Decide.
Let AI Decide.
600529
MDLN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Summarizing...
We need a little more time to summarize the results
Valuation Comparison
S
Intrinsic Value
26.34
CNY
Undervaluation 26%
M
MDLN
Intrinsic Value
Not Available
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
19.6
CNY
|
|||||
|
M
|
Medline Inc
NASDAQ:MDLN
|
42.16
USD
|
|||||
No Stocks Selected
Compare the stock's valuation with its competitors.
Valuation Scenario:
Growth Comparison
Growth Over Time
600529, MDLN
600529, MDLN
Revenue
www.alphaspread.com
No Stocks Selected
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
S
|
Shandong Pharmaceutical Glass Co Ltd
Revenue
|
|||||||||||
|
M
|
Medline Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
No Stocks Selected
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
600529, MDLN
600529, MDLN
Free Cash Flow
www.alphaspread.com
No Stocks Selected
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
|||||||||
|
M
|
Medline Inc
NASDAQ:MDLN
|
|||||||||
No Stocks Selected
Compare company's free cash flow with its competitors.
Gross Margin
Shandong Pharmaceutical Glass Co Ltd
31%
MDLN
26.4%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Pharmaceutical Glass Co Ltd | ||||
|
M
|
Medline Inc | ||||
Operating Margin
Shandong Pharmaceutical Glass Co Ltd
18.9%
MDLN
8.2%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Pharmaceutical Glass Co Ltd | ||||
|
M
|
Medline Inc | ||||
Net Margin
Shandong Pharmaceutical Glass Co Ltd
15.4%
MDLN
4.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Pharmaceutical Glass Co Ltd | ||||
|
M
|
Medline Inc | ||||
FCF Margin
Shandong Pharmaceutical Glass Co Ltd
7.7%
MDLN
4.6%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Pharmaceutical Glass Co Ltd | ||||
|
M
|
Medline Inc | ||||
ROE
Shandong Pharmaceutical Glass Co Ltd
8.5%
MDLN
10.8%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Pharmaceutical Glass Co Ltd | ||||
|
M
|
Medline Inc | ||||
ROA
Shandong Pharmaceutical Glass Co Ltd
6.8%
MDLN
3%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Pharmaceutical Glass Co Ltd | ||||
|
M
|
Medline Inc | ||||
ROIC
Shandong Pharmaceutical Glass Co Ltd
11.5%
MDLN
6.1%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Pharmaceutical Glass Co Ltd | ||||
|
M
|
Medline Inc | ||||
ROCE
Shandong Pharmaceutical Glass Co Ltd
10.2%
MDLN
6.5%
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Shandong Pharmaceutical Glass Co Ltd | ||||
|
M
|
Medline Inc | ||||
Solvency Comparison
S
Shandong Pharmaceutical Glass Co...
Equity Waterfall
Assets
Liabilities
Equity
No Stocks Selected
Compare company's equity waterfall with its competitors.
Balance Sheet Comparison
Stocks Performance
Stocks Performance
600529, MDLN
600529, MDLN
Performance Gap
600529, MDLN
600529, MDLN
Performance By Year
600529, MDLN
600529, MDLN
Loading
No Stocks Selected
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Compare 600529 to other stocks
7741
Hoya Corp
More expensive
vs Shandong Pharmaceutical Glass...
ALC
Alcon AG
More expensive
vs Shandong Pharmaceutical Glass...
COLO B
Coloplast A/S
Cheaper
vs Shandong Pharmaceutical Glass...
ALGN
Align Technology Inc
More expensive
vs Shandong Pharmaceutical Glass...
Select Stock to Compare
| JP |
|
Hoya Corp
TSE:7741
|
|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
|
| CH |
|
Alcon AG
SIX:ALC
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
|
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
Loading...
Unlock Full Access to Alpha Spread
Create Free Account
